Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

In follicular lymphoma (FL), progression of disease ≤24 months (POD24) has emerged as an important prognostic marker for overall survival (OS). We aimed to investigate survival more broadly by timing of progression and treatment in a national population-based setting. We identified 948 stage II-IV i...

Descripción completa

Detalles Bibliográficos
Autores principales: Weibull, Caroline E., Wästerlid, Tove, Wahlin, Björn Engelbrekt, Andersson, Per-Ola, Ekberg, Sara, Lockmer, Sandra, Enblad, Gunilla, Crowther, Michael J., Kimby, Eva, Smedby, Karin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953041/
https://www.ncbi.nlm.nih.gov/pubmed/36844185
http://dx.doi.org/10.1097/HS9.0000000000000838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953041/
https://www.ncbi.nlm.nih.gov/pubmed/36844185
http://dx.doi.org/10.1097/HS9.0000000000000838

Ejemplares similares